RPS6KB1 and breast carcinoma: The signaling response of concurrent targeting of both PI3K and mTOR pathways, as measured by phosphorylation of AKT and p70S6K respectively, did not predict growth inhibitory effects in MDA-MB-231, MDA-MB-436, BT20 and HCC1143 breast cancer cell lines.